Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000706919 | SCV000835994 | pathogenic | Autosomal recessive distal spinal muscular atrophy 1; Charcot-Marie-Tooth disease axonal type 2S | 2018-02-23 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in IGHMBP2 are known to be pathogenic (PMID: 14681881, 25439726, 25568292). This variant has not been reported in the literature in individuals with IGHMBP2-related disease. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Thr439Aspfs*62) in the IGHMBP2 gene. It is expected to result in an absent or disrupted protein product. |
Mendelics | RCV000988591 | SCV001138368 | likely pathogenic | Autosomal recessive distal spinal muscular atrophy 1 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
DASA | RCV001813800 | SCV002061244 | pathogenic | Neuronopathy, distal hereditary motor, autosomal dominant 1 | 2022-01-05 | criteria provided, single submitter | clinical testing | The c.1313dup;p.(Thr439Aspfs*62) is a null frameshift variant (NMD) in the IGHMBP2 gene and predicts alteration of the nonsense-mediate decay - NMD is present in a relevantexon to the transcript -PVS1. This sequence change has been observed in affected individual(s) and ClinVar contains an entry for this variant (ClinVar ID: 582766) - PS4. This variant is not present in population databases (rs1566443170, gnomAD; ABraOM no frequency - http://abraom.ib.usp.br/) - PM2. In summary, the currently available evidence indicates that the variant is pathogenic. |